Myo-leukoencephalopathy in twins: Study of 3243-myopathy, encephalopathy, lactic acidosis, and strokelike episodes mitochondrial DNA mutation

1994 ◽  
Vol 35 (3) ◽  
pp. 365-370 ◽  
Author(s):  
F. Degoul ◽  
M. Diry ◽  
A. Pou-Serradell ◽  
J. Lloreta ◽  
C. Marsac
2008 ◽  
Vol 39 (06) ◽  
pp. 328-334 ◽  
Author(s):  
E. W. Y. Tam ◽  
A. Feigenbaum ◽  
J. B. L. Addis ◽  
S. Blaser ◽  
N. MacKay ◽  
...  

1995 ◽  
Vol 18 (S14) ◽  
pp. S113-S118 ◽  
Author(s):  
Shuji Mita ◽  
Makoto Tokunaga ◽  
Toshihide Kumamoto ◽  
Makoto Uchino ◽  
Ikuya Nonaka ◽  
...  

2001 ◽  
Vol 9 (4) ◽  
pp. 311-315 ◽  
Author(s):  
Maurizia Grasso ◽  
Marta Diegoli ◽  
Agnese Brega ◽  
Carlo Campana ◽  
Luigi Tavazzi ◽  
...  

2017 ◽  
Vol 3 (3) ◽  
pp. e160 ◽  
Author(s):  
Sailaja Golla ◽  
Jimin Ren ◽  
Craig R. Malloy ◽  
Juan M. Pascual

Objective:There is a paucity of objective, quantifiable indicators of mitochondrial disease available for clinical and scientific investigation.Methods:To this end, we explore intramyocellular lipid (IMCL) accumulation noninvasively by 7T magnetic resonance spectroscopy (MRS) as a reporter of metabolic dysfunction in MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes). We reasoned that mitochondrial dysfunction may impair muscle fat metabolism, resulting in lipid deposition (as is sometimes observed in biopsies), and that MRS is well suited to quantify these lipids.Results:In 10 MELAS participants and relatives, IMCL abundance correlates with percent mitochondrial DNA mutation abundance and with disease severity.Conclusions:These results indicate that IMCL accumulation is a novel potential disease hallmark in MELAS.


2009 ◽  
Vol 390 (3) ◽  
pp. 755-757 ◽  
Author(s):  
Haris Kokotas ◽  
Maria Grigoriadou ◽  
George S. Korres ◽  
Elisabeth Ferekidou ◽  
Eleftheria Papadopoulou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document